Product introduction:
Ipratropium bromide, also known as ipratropium bromide, ipratropium bromide and ipratropium bromide. The chemical name is [(1R, 5S) - 8-methyl-8-isopropyl-8-azabicyclo [3.2.1] octyl-3-yl] 3-hydroxy-2-phenylpropionate bromide. It is a white or quasi white crystalline powder, soluble in water, easily soluble in methanol and slightly soluble in ethanol. Ipratropium bromide is a powerful anticholinergic drug with high selectivity for M receptor in bronchial smooth muscle. It is used to prevent and treat bronchial asthma and asthmatic chronic bronchitis, especially for use β Patients who cannot tolerate such drugs due to muscle tremor and tachycardia caused by receptor agonists, and β The combination of receptor agonists can enhance the curative effect of each other.
CAS:22254-24-6
Molecular formula: C20H30BrNO3
Molecular weight: 412.37
Structural type:
Product purpose:
Ipratropium bromide has strong relaxation effect on bronchial smooth muscle and antiasthmatic effect on chronic obstructive pulmonary disease. It has obvious effect, fast onset and long duration. Ipratropium bromide can also control the secretion of mucus glands and improve ciliary movement, so as to reduce sputum obstruction to improve ventilation. At the same time, the reduction of sputum also reduces bronchospasm caused by bronchial stimulation. It is used to prevent and treat bronchial asthma and asthmatic chronic bronchitis, especially for use β Patients with muscle tremor and tachycardia caused by receptor agonists and unable to tolerate such drugs.